Palliative Care CPGs Flashcards
The most commonly used route for medication administration in the palliative care setting is:
Subcutaneous
A person must have a life expectancy of no more than ___________ to receive benefits under the BC Palliative Care Benefits Program
6 months
What should be done with patient Goals of Care documents?
Take photos and attach to E-PCR
True or false; terminal delirium is a normal part of the dying process
False!
Although delirium often occurs 24 to 48 hours before death, it should not be considered a normal part of the dying process.
The three classes of delirium seen in palliative care patients are:
Hyperactive, hypoactive, and mixed
True or False; Physical restraints are a generally appropriate intervention in terminal delirium
False!
Avoid the use of physical restraints as they can increase the risk of delirium.
Attention disturbances, restlessness and agitation, and hallucinations are common symptoms of ____________ in palliative care patients
hyperactive delirium
Drowsiness, emotional or physical withdrawal, depression, lethargy, and decreased levels of consciousness are symptoms of _____________ in paliiative care patients
Hypoactive Delirium
List common causes of delirium in palliative care patients (up to 10)
- Sepsis
- Metabolic or electrolyte disturbances
- Hypoxia
- Organ failure
- Withdrawal from alcohol or medications
- Unmanaged or undermanaged pain
- Sleep deprivation
- Constipation or urinary retention
- Dehydration
- Changes to the patient’s environment or psychosocial situation
Medical management is typically reserved for which form of delirium?
hyperactive
The first line pharmaceutical choice for management of delirium in palliative care patients is (give agent, route, and dosage)
Benzodiazepines
- Midazolam
- Subcutaneous
- 5-10mg (no more than 30mg total from all sources)
- Lorazepam (ativan)
- Sublingual
- 1mg
- only if prescribed for patient; ACP must have appropriate Schedule 2 (4(b)) license endorsement
Delirium is a common (but not normal) finding in patients in the last __________ of life
24-48hrs
The second line pharmaceutical choice for management of delirium in palliative care patients is (give agent, route, and dosage)
- Ketamine
- SC/IM
- 0.1-0.5mg/kg
Patients requiring MIDAZOLam or ketAMINE for management of agitation should have a follow-up from their palliative care team; if care team unable to attend within an acceptable time frame, consider conveyance to hospital for further support
Describe how breakthrough dosing for analgesic medications is determined
- Breakthrough dosing is 10% of the TDD (total daily dose) from the previous days
- The total daily dose is the 24-hour total of a specific drug that is taken for regular and breakthrough pain.
- When switching between agents, use equianalgesic dosing conversions
A patient is prescribed 2mg hydromorphone QID (4/day) for analgesia. Yesterday they also self-adminstered 2 x 2mg “breakthrough” doses due to poorly controlled pain. Calculate breakthrough dosing today for them using:
- Hydromorphone (HM)
- Morphine Sulfate (MS)
- Oxycodone (OC)
TDD = 4x2mg + 2x2mg = 12mg HM
- Breakthrough = TDD x 0.10 = 12mg x 0.10 = 1.2mg SC
- MS dosing = 5 x HM dosing = 6mg SC
- OC dosing = 3.75 x HM dosing = 4.5mg PO